{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:17:57Z","timestamp":1773382677622,"version":"3.50.1"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"01","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Status epilepticus (SE) is the most severe presentation of epilepsy. Most available data on the treatment of SE refers to the convulsive type. Treatment begins with an accurate diagnosis, followed by clinical stabilization and rapid administration of benzodiazepines (BZDs). Then, treatment continues with the use of an intravenous antiseizure medication (ASM). Phenytoin has been the preferred ASM as the second-line treatment of SE (after failure of BZDs to control seizures), although this choice was mostly guided by low-quality evidence. Recent evidence demonstrates that levetiracetam is at least as effective as phenytoin in the treatment of convulsive SE, both in adults and children. Moreover, growing evidence indicates that levetiracetam offers better tolerability and a more favorable safety profile. Therefore, in this Point of View, we argue that we should retire phenytoin in the treatment of convulsive SE, and levetiracetam should become the first choice of treatment.<\/jats:p>","DOI":"10.1055\/s-0046-1817042","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:08:02Z","timestamp":1773360482000},"page":"001-004","source":"Crossref","is-referenced-by-count":0,"title":["Let's retire phenytoin! Levetiracetam as the first choice in the treatment of convulsive status epilepticus"],"prefix":"10.1055","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4956-5542","authenticated-orcid":false,"given":"Luis Ot\u00e1vio","family":"Caboclo","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo SP, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7031-0464","authenticated-orcid":false,"given":"Carol Ladeia Lopes","family":"Frota","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo SP, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"E Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"03","key":"ref2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ana.25416","article-title":"Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE)","volume":"85","author":"C Kellinghaus","year":"2019","journal-title":"Ann Neurol"},{"issue":"01","key":"ref3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.annemergmed.2024.02.018","article-title":"Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Seizures: Approved by the ACEP Board of Directors, April 17, 2024","volume":"84","author":"M D Smith","year":"2024","journal-title":"Ann Emerg Med"},{"issue":"01","key":"ref4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"T Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"issue":"07","key":"ref5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"R Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"issue":"01","key":"ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"G M Brophy","year":"2012","journal-title":"Neurocrit Care"},{"issue":"12","key":"ref7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus","volume":"339","author":"D M Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"01","key":"ref8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5863\/1551-6776-25.1.4","article-title":"Status Epilepticus: The Slow and Agonizing Death of Phenytoin","volume":"25","author":"E A Hall","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"03","key":"ref9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Z Yasiry","year":"2014","journal-title":"Seizure"},{"issue":"20","key":"ref10","doi-asserted-by":"publisher","first-page":"e2339","DOI":"10.1212\/WNL.0000000000007503","article-title":"Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus","volume":"92","author":"I S Fern\u00e1ndez","year":"2019","journal-title":"Neurology"},{"issue":"22","key":"ref11","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus","volume":"381","author":"J Kapur","year":"2019","journal-title":"N Engl J Med"},{"issue":"01","key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0045-1801872","article-title":"Treatment of convulsive status epilepticus in Brazil: a review","volume":"83","author":"L O Caboclo","year":"2025","journal-title":"Arq Neuropsiquiatr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"S R Dalziel","year":"2019","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"M D Lyttle","year":"2019","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jocn.2021.05.004","article-title":"Comparison of the efficacy and safety of levetiracetam and phenytoin in the treatment of established status epilepticus: A systematic review and meta-analysis","volume":"89","author":"L Yang","year":"2021","journal-title":"J Clin Neurosci"},{"issue":"01","key":"ref16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12883-025-04323-0","article-title":"Efficacy and safety of levetiracetam for pediatric convulsive status epilepticus in emergency settings: a systematic review and meta-analysis","volume":"25","author":"M Alsabri","year":"2025","journal-title":"BMC Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1580329","DOI":"10.3389\/fneur.2025.1580329","article-title":"Levetiracetam versus phenytoin\/fosphenytoin for second-line treatment of children with convulsive status epilepticus: an up-to-date meta-analysis and systematic review of randomized controlled trials","volume":"16","author":"L Jin","year":"2025","journal-title":"Front Neurol"},{"issue":"03","key":"ref18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/epi.17872","article-title":"Rapid administration of undiluted loading doses of levetiracetam","volume":"65","author":"S Martinez","year":"2024","journal-title":"Epilepsia"},{"issue":"07","key":"ref19","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","article-title":"Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study","volume":"47","author":"S Ramael","year":"2006","journal-title":"Epilepsia"},{"issue":"08","key":"ref20","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/epi.16961","article-title":"Rapid administration of undiluted intravenous levetiracetam","volume":"62","author":"J T Haller","year":"2021","journal-title":"Epilepsia"},{"issue":"04","key":"ref21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1212\/WNL.0b013e31829c5cfe","article-title":"Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality","volume":"81","author":"N S Abend","year":"2013","journal-title":"Neurology"},{"issue":"01","key":"ref22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/jnnp-2022-329485","article-title":"Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial","volume":"94","author":"K Nakamura","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref23","first-page":"435","article-title":"Phenytoin: relevant side effects","volume":"27","author":"H Kutt","year":"1980","journal-title":"Adv Neurol"},{"issue":"01","key":"ref24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1528-1167.2012.03563.x","article-title":"Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study","volume":"54","author":"K L Fuller","year":"2013","journal-title":"Epilepsia"},{"issue":"04","key":"ref25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3171\/jns.1999.91.4.0588","article-title":"Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis","volume":"91","author":"A M Haltiner","year":"1999","journal-title":"J Neurosurg"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0046-1817042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:08:06Z","timestamp":1773360486000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0046-1817042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2026,1,25]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["s00461817042"],"URL":"https:\/\/doi.org\/10.1055\/s-0046-1817042","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}